• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Overview
    • Buy Sell Zone
    • F&O
    • Financials
    • News
      All News Earnings Calls Corporate Announcements Research Reports
    • Reports
    • Technicals
      Technicals Share Price History Delivery
    • Shareholding
      Shareholding Monthly MF Holdings Bulk Block Deals Insider Trading & SAST
    • Deals
      Bulk Block Deals Insider Trading & SAST
    • Corporate Actions
      All Dividend Bonus Split Rights Board Meetings
    • Alerts (2)
    • About

    Biocon Ltd.

    NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
    US FDA Approval
    | Mid-range Performer
    369.2000 0.80 (0.22%)
    NSE Sep 19, 2025 15:31 PM
    26.87% Gain from 52W Low
    Volume: 14.2M
    High volume today
    • Share on Facebook
    • Tweet
    • Share on LinkedIn
    • Share via Whatsapp

    logo
    Biocon Ltd.
    17 Sep 2021
    US FDA Approval
    369.20
    0.22%
    Serum-Biocon alliance to make India a global vaccine manufacturing powerhouse: SII
    Serum-Biocon alliance to make India a global vaccine manufacturing powerhouse: SII
    livemint
    Biocon Biologics Limited, a subsidiary of Biocon, on Thursday announced a strategic alliance with Serum Institute Life Sciences, a subsidiary of SII
    Copy Link Share on Share on Share on Share on
    Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.
    Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
    NDTV Profit | 17 Sep 2021 4 more
    The daily dose: September 17, 2021
    Business Line | 17 Sep 2021
    Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
    Business Standard | 16 Sep 2021
    Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
    Business Line | 16 Sep 2021
    Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
    livemint | 16 Sep 2021
    More from Biocon Ltd.
    Recommended
    Five Interesting Stocks Today - September 19, 2025
    The Baseline | 19 Sep 2025, 04:31PM
    Market closes lower, JSW Energy arm to acquire Tidong Power
    Trendlyne Marketwatch | 19 Sep 2025, 03:58PM
    A long drawn out R&D plan may be finally paying off for Biocon
    | 20 Aug 2020, 08:47AM
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • JD Cables
    • GK Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd